The scientists running the Com-COV trial have launched a new study of COVID-19 vaccination schedules in young people aged 12 to 16.
This was a Q&A for journalists to have the opportunity to be able to ask Prof Matthew Snape any questions about how the trial will work, what will be involved etc.
Speakers included:
Prof Matthew Snape, Associate Professor in Paediatrics and Vaccinology, University of Oxford, and Chief Investigator of the Com-COV trial